FR2186967A5 - - Google Patents

Info

Publication number
FR2186967A5
FR2186967A5 FR7210632A FR7210632A FR2186967A5 FR 2186967 A5 FR2186967 A5 FR 2186967A5 FR 7210632 A FR7210632 A FR 7210632A FR 7210632 A FR7210632 A FR 7210632A FR 2186967 A5 FR2186967 A5 FR 2186967A5
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7210632A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Application granted granted Critical
Publication of FR2186967A5 publication Critical patent/FR2186967A5/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
FR7210632A 1970-05-05 1972-03-27 Expired FR2186967A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2023122A DE2023122C3 (de) 1970-05-05 1970-05-05 Verfahren zur Herstellung von Pregnen-Derivaten

Publications (1)

Publication Number Publication Date
FR2186967A5 true FR2186967A5 (fr) 1974-01-11

Family

ID=5770879

Family Applications (2)

Application Number Title Priority Date Filing Date
FR717116011A Expired FR2088348B1 (fr) 1970-05-05 1971-05-04
FR7210632A Expired FR2186967A5 (fr) 1970-05-05 1972-03-27

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR717116011A Expired FR2088348B1 (fr) 1970-05-05 1971-05-04

Country Status (20)

Country Link
US (1) US3741997A (fr)
JP (1) JPS5511680B1 (fr)
AT (1) AT312175B (fr)
BE (1) BE766739A (fr)
CH (2) CH609708A5 (fr)
CS (1) CS174159B2 (fr)
DE (1) DE2023122C3 (fr)
DK (1) DK128895B (fr)
ES (1) ES390906A1 (fr)
FR (2) FR2088348B1 (fr)
GB (1) GB1352027A (fr)
HU (1) HU162673B (fr)
IE (1) IE35194B1 (fr)
IL (1) IL36754A (fr)
NL (1) NL169883C (fr)
PH (1) PH9298A (fr)
PL (1) PL81585B1 (fr)
SE (1) SE371820B (fr)
SU (1) SU440830A3 (fr)
ZA (1) ZA712675B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2230286C3 (de) * 1972-06-16 1981-09-24 Schering Ag Berlin Und Bergkamen, 1000 Berlin Verfahren zur Herstellung von Pregnan-Derivaten
DE2625306C2 (de) * 1976-06-02 1978-06-15 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von Pregnan-Derivaten
DE3260444D1 (en) * 1981-04-16 1984-08-30 Richter Gedeon Vegyeszet Process for the preparation of pregn-4-ene-3,20-dione derivatives and 17-alpha-ethynyl-17-beta-trifluoroacetoxy-gon-4-ene-3-one derivatives, and pharmaceutical compositions containing the latter compounds
JPS5835165U (ja) * 1981-08-31 1983-03-07 クラリオン株式会社 テ−ププレ−ヤの頭出し機構
US4588529A (en) * 1985-02-28 1986-05-13 The Upjohn Company Mercury removal process
US6569464B1 (en) * 2001-03-30 2003-05-27 Council Of Scientific & Industrial Research Coelomic fluid extract from Pheretima posthuma for providing sperm immotility

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3485852A (en) * 1958-11-13 1969-12-23 Syntex Corp 6-halo-6-dehydro-progesterones
US3465009A (en) * 1967-10-13 1969-09-02 American Home Prod Novel intermediates in the preparation of 13 - polycarbonalkyl - 17alpha - hydroxy-18,19 - dinorpregn - 4 - en - 3,20 - diones and acylates thereof

Also Published As

Publication number Publication date
IL36754A0 (en) 1971-07-28
DE2023122C3 (de) 1979-11-22
CH609708A5 (fr) 1979-03-15
FR2088348B1 (fr) 1973-06-08
GB1352027A (en) 1974-05-15
ZA712675B (en) 1972-01-26
JPS5511680B1 (fr) 1980-03-26
DE2023122A1 (de) 1971-11-18
AT312175B (de) 1973-12-27
PL81585B1 (fr) 1975-08-30
IE35194L (en) 1971-11-05
IL36754A (en) 1975-02-10
US3741997A (en) 1973-06-26
DK128895B (da) 1974-07-22
NL7106175A (fr) 1971-11-09
SE371820B (fr) 1974-12-02
CH620451A5 (fr) 1980-11-28
IE35194B1 (en) 1975-12-10
NL169883B (nl) 1982-04-01
DE2023122B2 (de) 1979-03-29
NL169883C (nl) 1982-09-01
HU162673B (fr) 1973-03-28
SU440830A3 (fr) 1974-08-25
CS174159B2 (fr) 1977-03-31
PH9298A (en) 1975-08-15
FR2088348A1 (fr) 1972-01-07
ES390906A1 (es) 1973-06-01
BE766739A (fr) 1971-11-05

Similar Documents

Publication Publication Date Title
ATA96471A (fr)
AU1146470A (fr)
AU2044470A (fr)
AU1326870A (fr)
AU2130570A (fr)
AU2085370A (fr)
AU2017870A (fr)
AU1833270A (fr)
AU1716970A (fr)
AU1517670A (fr)
AU1336970A (fr)
AR195465A1 (fr)
AU1591370A (fr)
AU1064870A (fr)
AU2144270A (fr)
AU2131570A (fr)
AU2130770A (fr)
AU1328670A (fr)
AU1277070A (fr)
AU1343870A (fr)
AU1247570A (fr)
ATA672271A (fr)
AU2119370A (fr)
AU1581370A (fr)
AU1235770A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse